| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;118:1410-1418.)
© 2008 American Heart Association, Inc.
Congenital Heart Disease |
From the Department of Pediatrics (J.A., A.R.J., C.M.T.R., J.D.D., I.M.R.), School of Public Health (I.A.D.), and Department of Surgery (D.B.R., I.M.R.), University of Alberta, Edmonton, Alberta, Canada; Pediatric Rehabilitation Outcomes Evaluation and Research Unit (C.M.T.R.), Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada; and Department of Pediatrics (R.S.S.), University of Calgary, Calgary, Alberta, Canada.
Correspondence to Ari Joffe, MD, FRCP(C), Department of Pediatrics, 3A3.07 Stollery Childrens Hospital, 8440 112 St, Edmonton, Alberta, Canada T6G 2B7. E-mail ajoffe{at}cha.ab.ca
Received September 24, 2007; accepted July 25, 2008.
| Abstract |
|---|
|
|
|---|
Methods and Results— Between September 1996 and July 2005, 94 neonates with hypoplastic left heart syndrome underwent the Norwood procedure. Patients were recruited as neonates and followed up prospectively. Health, mental, and psychomotor outcomes (Bayley Scales of Infant Development-II) were assessed at 2 years. The study subjects were from the Norwood-MBTS era (n=62; 1996 to 2002) or the Norwood-RVPA era (n=32; 2002 to 2005). In the MBTS era, early and 2-year mortality rates were 23% (14/62) and 52% (32/62); the mean (SD) mental and psychomotor developmental indices were 79 (18) and 67 (19). In the RVPA era, early and 2-year mortality rates were 6% (2/32) and 19% (6/32); the mean (SD) mental and psychomotor developmental indices were 85 (18) and 78 (18). The 2-year mortality rate (P=0.002) and the psychomotor developmental index (P=0.029) were improved in the more recent surgical era. On multivariable Cox regression analysis, postoperative highest serum lactate independently predicted 2-year mortality in the MBTS and RVPA eras.
Conclusions— Analysis of 2 consecutive surgical eras of hypoplastic left heart syndrome patients undergoing the Norwood procedure showed a significant improvement in 2-year survival and psychomotor development in the more recent era. Adverse neurodevelopmental outcome in this patient population remains a concern.
Key Words: heart defects, congenital pediatrics mortality prognosis
| Introduction |
|---|
|
|
|---|
Clinical Perspective p 1418
| Methods |
|---|
|
|
|---|
6 weeks of age were identified at the time of complex cardiac surgery and were followed up prospectively. In the present study, we included all patients with the diagnosis of HLHS or its variants who had undergone the Norwood procedure between September 1996 and July 2005. All surgeries were performed at the Stollery Childrens Hospital, Edmonton, Alberta, Canada. Predetermined demographic, preoperative, intraoperative, and postoperative variables were collected prospectively.11,12 Long-term follow-up was discussed with parents or guardians once survival was probable, and with their written consent, contact was made with their respective follow-up clinics at the tertiary site of origin.
Early Childhood Assessments
Outcome assessments were completed when the children were between 18 and 24 months of age. History and physical measurements were obtained as described previously.11,12 The family socioeconomic status was determined with the Blishen Index.13 Maternal education was indicated by years of schooling. Pediatricians experienced in neurodevelopmental follow-up examined each child for evidence of cerebral palsy14 or visual impairment, defined as corrected visual acuity in the better eye of <20/60.11,12 Hearing was evaluated by experienced certified pediatric audiologists in soundproof environments as described previously.11,12 Sensorineural hearing impairment was defined as responses in the better ear of >40 dB at any frequency from 250 to 4000 Hz. Five certified pediatric psychologists and psychometrists administered the Bayley Scales of Infant Development-II15 in their respective referral institutions. The Bayley Scales of Infant Development-II is a widely accepted standardized outcome measure used in neonatal follow-up clinics that yields separate mental developmental index (MDI) and psychomotor developmental index (PDI) standardized scores with a mean of 100 and SD of 15. Developmental indices of <70 (2 SD below the mean) indicated mental or psychomotor delay. Within a normative sample, 2.27% of children have scores <70.
Variables
Demographic, preoperative, intraoperative, postoperative, and overall variables used in the study are listed in Table 1
.
|
|
Outcomes
The primary outcomes of interest were (1) mortality (early, interim, and 2-year) and (2) mental and motor development. Early mortality was defined as death that occurred within 30 days of the Norwood procedure or at any time in the hospital if the patient was never discharged. Interim mortality was defined as death that occurred after the above-defined early mortality period and before the bidirectional cavopulmonary anastomosis surgical procedure. Two-year mortality included all deaths that occurred between the Norwood procedure and the 2-year birth date, inclusive. Secondary outcomes included morbidity, defined by the health and growth variables listed in Table 2.
|
Statistical Analysis
Continuous variables are presented as mean (SD) and were analyzed with the Student t test. Categorical variables are presented as counts and percentages and were analyzed with Fisher exact test. Actuarial survival analysis was performed with Kaplan-Meier estimates with log-rank comparison of cumulative survival by study era. Mortality and mental and psychomotor development were analyzed for the 2 study groups separately. To screen for variables associated with early and 2-year mortality, we used univariate logistic and Cox regression analysis, respectively, and included all relevant variables from Table 1
. Multivariable logistic and Cox regression analysis included variables that were significant at P
0.10 in the corresponding univariate analysis. To screen for variables associated with MDI and PDI, we used univariate logistic regression models and included all relevant variables from Table 1
. Multiple linear regression models consisted of variables found to be significant at P
0.10 in the univariate analysis, after screening for multicollinearity. Regression model results are reported as hazard ratios or effect sizes with confidence intervals and 2-sided P values. Statistical analyses were performed with SAS version 9.1 (SAS Institute Inc, Cary, NC).
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
Group Comparison
The demographic, preoperative, operative, postoperative, and overall variables compared between the MBTS and RVPA eras are shown in Table 1
. Noncardiac diagnoses are listed in Table I in the online-only Data Supplement.
Primary Outcomes
Mortality
Early mortality was 23% (14/62) for the MBTS era and 6% (2/32) for the RVPA era (P=0.079). Interim mortality was 21% (13/62) for the MBTS era and 13% (4/32) for the RVPA era (P=0.403). Mortality by 2 years of age was 52% (32/62) for the MBTS era and 19% (6/32) for the RVPA era (P=0.002). Kaplan-Meier estimates of survival time after the Norwood surgery show significantly better survival at 2 years of age for the RVPA era than for the MBTS era (P=0.003; Figure 1).
|
For early mortality, multiple logistic regression analysis was performed only for the MBTS era, adjusted for variables listed in Table 1
(see online-only Data Supplement Table II for univariate analysis). Highest lactate on postoperative days 2 to 5 (odds ratio 1.14, 95% confidence interval 1.03 to 1.27, P=0.016) and male sex (odds ratio 0.23, 95% confidence interval 0.05 to 1.07, P=0.062) were associated with early mortality. When the multiple logistic regression was repeated with the exclusion of postoperative variables, only male sex was associated with early mortality. Multiple regression analysis for early mortality was not performed for the RVPA era, because the outcome consisted of only 2 deaths.
For mortality by 2 years of age, multivariable Cox regression analysis was performed for the MBTS era and the RVPA era separately and adjusted for variables listed in Table 1
(see online-only Data Supplement Table III for univariate analysis). The results are shown in Table 3.
|
Mental and Psychomotor Outcomes
Survivors were assessed with the Bayley Scales of Infant Development-II at 21.4 (4.2) and 21.9 (4.5) months in the RVPA and MBTS eras, respectively (P=0.695). The mean MDI scores in the RVPA and MBTS eras were not statistically significantly different (Table 2). The mean PDI scores were significantly higher and the incidence of psychomotor delay (score <70) was significantly lower in the RVPA era (Table 2; Figure 2).
|
Multiple linear regression analysis, performed for the MBTS era and the RVPA era separately, included variables found to be significantly related to mental and psychomotor scores (P
0.10) in the univariate logistic regression analysis (online-only Data Supplement Table IV). The results are shown in Table 4.
|
Secondary Outcomes
Overall, no difference was found in the growth and health outcomes as listed in Table 4, except for sensorineural hearing loss, which occurred more often in patients in the RVPA era. Six patients (5 with RVPA shunt) required amplification (Table 2).
| Discussion |
|---|
|
|
|---|
Early Mortality
We found a trend to lower early mortality in the more recent RVPA surgical era; however, the present study was not powered to show this difference as statistically significant. Pizarro et al4 and Griselli et al8 reported a similar decrease in early mortality. On the other hand, other series identified no difference in early mortality between the MBTS and RVPA groups.5,7,10 In the late 1990s, reports on early mortality after the Norwood-MBTS ranged from 7% to 29%.24–27 A more recent study reported a 21% early mortality, with noncardiac abnormalities and birth weight <2.5 kg identified as risk factors.28 In the present study, multiple logistic regression analysis showed that postoperative serum lactate and male sex were independent predictors of early mortality in the MBTS era. Cheung et al29 previously identified postoperative lactate as a predictor of early mortality after neonatal surgery.
Interim Mortality
The difference in interim mortality did not reach statistical significance. Most comparative reports of interim death demonstrate a decreased incidence in the RVPA patient population compared with the MBTS population.4–6 Previous reports analyzing patients undergoing the Norwood-MBTS in the 1990s reported interim mortality rates of 13%24 and 15%.25 Overall, interim mortality appears to be declining. It is still not negligible, however, and remains an important clinical concern. The benefit of the home surveillance program in decreasing interim mortality documented by others16 could not be confirmed in the present study cohort.
Two-Year Mortality
We found a significantly lower mortality rate by 2 years of age in the RVPA era. In the late 1990s, MBTS mortality rates were reported at 28%24 and 34%.27 Sano et al,30 in a multi-institutional study, reported a 37% 2-year mortality rate for an RVPA cohort. Two recent studies reported similar MBTS versus RVPA late mortality rates of 32% versus 30%5 and 31% versus 27%,10 respectively. In the present study, multivariable Cox regression analysis identified postoperative serum lactate and base deficit as statistically significant predictors of mortality by 2 years of age in the MBTS era. In the RVPA era, a higher postoperative serum lactate was the only independent predictor of mortality by 2 years of age.
Bidirectional Cavopulmonary Anastomosis
The bidirectional cavopulmonary anastomosis procedure was performed at a younger age in the RVPA era. This earlier timing has been observed by others5,7,10 and is thought to be due to earlier cyanosis.7 Another study showed no difference in the timing of the bidirectional cavopulmonary anastomosis between the MBTS and RVPA groups.31 The earlier timing of bidirectional cavopulmonary anastomosis may also be related to a gradual change in the medico-surgical practice toward earlier relief of the right ventricular volume overload and shortening of the high-risk interim period. There has been some theoretical concern about poor growth of the pulmonary arteries after RVPA; however, recent studies showed that the RVPA conduit provided better growth of the pulmonary arteries than the MBTS.31,32
Mental and Psychomotor Outcomes
Some infants undergoing complex surgery for congenital heart disease have an abnormal neurodevelopmental outcome when evaluated at as early as 1 or 2 years of life.11,33–35 Mahle et al36 evaluated 115 of 138 eligible surgically palliated school-aged and adolescent children with HLHS using mailed questionnaires. They found that performance correlated with the incidence of preoperative seizures and cumulative duration of cardiopulmonary bypass. Standardized neurocognitive evaluation was performed on 28 of 34 patients, who were eligible if they lived within a local geographic region and if English was their primary language used at home. Eighteen percent (5/28) had IQ scores in the mentally retarded range. Other studies have reported the significant risk for adverse neurodevelopmental outcome in HLHS patients.37–40 One study showed the duration of DHCA to be inversely associated with performance IQ in a small cohort of 14 patients.39 For children after Norwood MBTS surgery, a strong correlation has been found between the MDI at 18 to 24 months of age and full-scale intelligence scores at 5 years of age.41
In the present study cohort, MDI scores and the incidence of mental delay did not improve in the recent surgical era. Linear regression analysis identified a lower socioeconomic status and prolonged hospitalization at the time of the Norwood procedure as independent predictors of lower mental scores in the MBTS era. In the RVPA era, lower PaO2 and longer ventilation time (days) before the Norwood procedure, as well as longer DHCA time during the Norwood procedure, were independent predictors of lower mental scores. Robertson et al11 previously identified preoperative ventilation as a significant predictor of neurodevelopmental outcome after neonatal open heart surgery. Longer hospitalization was identified previously as an independent predictor of lower full-scale IQ scores in a cohort of school-aged HLHS patients who had undergone either the Norwood procedure or heart transplantation.42
The present results showed a significant improvement in PDI scores and a lower incidence of psychomotor delay in the RVPA era. Linear regression analysis identified only male sex as an independent predictor of lower psychomotor scores in the MBTS era. In the RVPA era, longer overall hospitalization and the need for cardiopulmonary resuscitation at any time before or after the Norwood procedure were independent predictors of a lower psychomotor score.
The use of regional cerebral perfusion was not a significant predictor of MDI or PDI scores in the MBTS era. Regional cerebral perfusion was used, however, in all patients in the RVPA era and thus could not be analyzed as a predictor. A recent retrospective study43 and a recent randomized clinical trial44 compared the neurodevelopmental outcome of patients undergoing the Norwood procedure with and without low-flow regional cerebral perfusion and showed no difference in the Bayley Scales of Infant Development-II scores when assessed at 1 year of age.
Sensorineural hearing loss occurred more commonly in the RVPA era. This degree of hearing loss, even if amplified, may have reduced the MDI scores among RVPA survivors. The cause of the hearing loss remains unknown.45 An unexpectedly high prevalence of sensorineural hearing loss has been reported previously among children with congenital heart defects.46
The results of the present study must be interpreted in the context of its nonrandomized study design and the use of a single surgical center and consecutive surgical eras. The inception cohort size limited the statistical power of the study. Nevertheless, the study included a large number of variables, and there was no loss to follow-up. We cannot determine whether the finding of improved outcomes in the RVPA era is a cause-effect relationship attributable to the change in surgical shunt technique only, because many known or unidentified changes in practice over the years may account for the findings.
Conclusions
An analysis of 2 consecutive surgical eras showed that HLHS patients undergoing the Norwood procedure have experienced significant improvement in their survival to 2 years of age and in their psychomotor developmental outcome without any significant adverse change in general health or mental outcome. Survival and developmental outcome predictors varied between the 2 surgical eras and included modifiable and nonmodifiable variables. Further research in this field is needed, because adverse neurodevelopmental outcome in this patient population remains a concern.
| Acknowledgments |
|---|
Sources of Funding
Financial support was initially provided by the Glenrose Rehabilitation Hospital Research Trust Fund, with ongoing operational funding from The Registry and Follow-up of Complex Pediatric Therapies Project, Alberta Health and Wellness.
Disclosures
None.
| References |
|---|
|
|
|---|
2. Kishimoto H, Kawahira Y, Kawata H, Miura T, Iwai S, Mori T. The modified Norwood palliation on a beating heart. J Thorac Cardiovasc Surg. 1999; 118: 1130–1132.
3. Sano S, Ishino K, Kawada M, Arai S, Kasahara S, Asai T, Masuda Z, Takeuchi M, Ohtsuki S. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2003; 126: 504–509.
4. Pizarro C, Mroczek T, Malec E, Norwood WI. Right ventricle to pulmonary artery conduit reduces interim mortality after stage 1 Norwood for hypoplastic left heart syndrome. Ann Thorac Surg. 2004; 78: 1959–1963.
5. Tabbutt S, Dominguez TE, Ravishankar C, Marino BS, Gruber PJ, Wernovsky G, Gaynor JW, Nicolson SC, Spray TL. Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg. 2005; 80: 1582–1590.
6. Cua CL, Thiagarajan RR, Taeed R, Hoffman TM, Lai L, Hayes J, Laussen PC, Feltes TF. Improved interstage mortality with the modified Norwood procedure: a meta-analysis. Ann Thorac Surg. 2005; 80: 44–49.
7. Cua CL, Thiagarajan RR, Gauvreau K, Lai L, Costello JM, Wessel DL, Del Nido PJ, Mayer JE Jr, Newburger JW, Laussen PC. Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit. Pediatr Crit Care Med. 2006; 7: 238–244.[CrossRef][Medline] [Order article via Infotrieve]
8. Griselli M, McGuirk SP, Stumper O, Clarke AJ, Miller P, Dhillon R, Wright JG, de Giovanni JV, Barron DJ, Brawn WJ. Influence of surgical strategies on outcome after the Norwood procedure. J Thorac Cardiovasc Surg. 2006; 131: 418–426.
9. McGuirk SP, Griselli M, Stumper OF, Rumball EM, Miller P, Dhillon R, de Giovanni JV, Wright JG, Barron DJ, Brawn WJ. Staged surgical management of hypoplastic left heart syndrome: a single institution 12 year experience. Heart. 2006; 92: 364–370.
10. Ballweg JA, Dominguez TE, Ravishankar C, Kreutzer J, Marino BS, Bird GL, Gruber PJ, Wernovsky G, Gaynor JW, Nicolson SC, Spray TL, Tabbutt S. A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at stage 2 reconstruction. J Thorac Cardiovasc Surg. 2007; 134: 297–303.
11. Robertson CM, Joffe AR, Sauve RS, Rebeyka IM, Phillipos EZ, Dyck JD, Harder JR. Outcomes from an interprovincial program of newborn open heart surgery. J Pediatr. 2004; 144: 86–92.[CrossRef][Medline] [Order article via Infotrieve]
12. Freed DH, Robertson CM, Sauve RS, Joffe AR, Rebeyka IM, Ross DB, Dyck JD. Intermediate-term outcomes of the arterial switch operation for transposition of great arteries in neonates: alive but well? J Thorac Cardiovasc Surg. 2006; 132: 845–852.
13. Blishen BR. The 1981socioeconomic index for occupations in Canada. Can Rev Soc Anthropol. 1987; 24: 465–488.
14. Bax MC. Terminology and classification of cerebral palsy. Dev Med Child Neurol. 1964; 11: 295–297.
15. Bayley N. Manual: Bayley Scales of Infant Development. 2nd ed. San Antonio, Tex: Psychological Corp; 1993.
16. Ghanayem NS, Hoffman GM, Mussatto KA, Cava JR, Frommelt PC, Rudd NA, Steltzer MM, Bevandic SM, Frisbee SS, Jaquiss RD, Litwin SB, Tweddell JS. Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg. 2003; 126: 1367–1377.
17. Report of the New England Regional Infant Cardiac Program. Pediatrics. 1980; 65: 375–461.[Medline] [Order article via Infotrieve]
18. Malec E, Januszewska K, Kolcz J, Mroczek T. Right ventricle-to-pulmonary artery shunt versus modified Blalock-Taussig shunt in the Norwood procedure for hypoplastic left heart syndrome: influence on early and late haemodynamic status. Eur J Cardiothorac Surg. 2003; 23: 728–733.
19. Mahle WT, Cuadrado AR, Tam VK. Early experience with a modified Norwood procedure using right ventricle to pulmonary artery conduit. Ann Thorac Surg. 2003; 76: 1084–1088.
20. Azakie A, Martinez D, Sapru A, Fineman J, Teitel D, Karl TR. Impact of right ventricle to pulmonary artery conduit on outcome of the modified Norwood procedure. Ann Thorac Surg. 2004; 77: 1727–1733.
21. Pizarro C, Malec E, Maher KO, Januszewska K, Gidding SS, Murdison KA, Baffa JM, Norwood WI. Right ventricle to pulmonary artery conduit improves outcome after stage I Norwood for hypoplastic left heart syndrome. Circulation. 2003; 108 (suppl 1): II-155–II-160.
22. Maher KO, Pizarro C, Gidding SS, Januszewska K, Malec E, Norwood WI Jr, Murphy JD. Hemodynamic profile after the Norwood procedure with right ventricle to pulmonary artery conduit. Circulation. 2003; 108: 782–784.
23. Mair R, Tulzer G, Sames E, Gitter R, Lechner E, Steiner J, Hofer A, Geiselseder G, Gross C. Right ventricular to pulmonary artery conduit instead of modified Blalock-Taussig shunt improves postoperative hemodynamics in newborns after the Norwood operation. J Thorac Cardiovasc Surg. 2003; 126: 1378–1384.
24. Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RD, Ghanayem NS, Frisbee SJ, Litwin SB. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation. 2002; 106 (suppl I): I-82–I-89.
25. Azakie T, Merklinger SL, McCrindle BW, Van Arsdell GS, Lee KJ, Benson LN, Coles JG, Williams WG. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience. Ann Thorac Surg. 2001; 72: 1349–1353.
26. Gaynor JW, Mahle WT, Cohen MI, Ittenbach RF, DeCampli WM, Steven JM, Nicolson SC, Spray TL. Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg. 2002; 22: 82–89.
27. Mahle WT, Spray TL, Wernovsky G, Gaynor JW, Clark BJ III. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation. 2000; 102 (suppl III): III-136–III-141.
28. Stasik CN, Gelehrter S, Goldberg CS, Bove EL, Devaney EJ, Ohye RG. Current outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg. 2006; 131: 412–417.
29. Cheung PY, Chui N, Joffe AR, Rebeyka IM, Robertson CM. Postoperative lactate concentrations predict the outcome of infants aged 6 weeks or less after intracardiac surgery: a cohort follow-up to 18 months. J Thorac Cardiovasc Surg. 2005; 130: 837–843.
30. Sano S, Ishino K, Kado H, Shiokawa Y, Sakamoto K, Yokota M, Kawada M. Outcome of right ventricle-to-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome: a multi-institutional study. Ann Thorac Surg. 2004; 78: 1951–1957.
31. Januszewska K, Kolcz J, Mroczek T, Procelewska M, Malec E. Right ventricle-to-pulmonary artery shunt and modified Blalock-Taussig shunt in preparation to hemi-Fontan procedure in children with hypoplastic left heart syndrome. Eur J Cardiothorac Surg. 2005; 27: 956–961.
32. Rumball EM, McGuirk SP, Stumper O, Laker SJ, de Giovanni JV, Wright JG, Barron DJ, Brawn WJ. The RV-PA conduit stimulates better growth of the pulmonary arteries in hypoplastic left heart syndrome. Eur J Cardiothorac Surg. 2005; 27: 801–806.
33. Wernovsky G, Shillingford AJ, Gaynor JW. Central nervous system outcomes in children with complex congenital heart disease. Curr Opin Cardiol. 2005; 20: 94–99.[CrossRef][Medline] [Order article via Infotrieve]
34. Dittrich H, Buhrer C, Grimmer I, Dittrich S, Abdul-Khaliq H, Lange PE. Neurodevelopment at 1 year of age in infants with congenital heart disease. Heart. 2003; 89: 436–441.
35. Robertson DR, Justo RN, Burke CJ, Pohlner PG, Graham PL, Colditz PB. Perioperative predictors of developmental outcome following cardiac surgery in infancy. Cardiol Young. 2004; 14: 389–395.[CrossRef][Medline] [Order article via Infotrieve]
36. Mahle WT, Clancy RR, Moss EM, Gerdes M, Jobes DR, Wernovsky G. Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome. Pediatrics. 2000; 105: 1082–1089.
37. Wernovsky G, Stiles KM, Gauvreau K, Gentles TL, duPlessis AJ, Bellinger DC, Walsh AZ, Burnett J, Jonas RA, Mayer JE Jr, Newburger JW. Cognitive development after the Fontan operation. Circulation. 2000; 102: 883–889.
38. Rogers BT, Msall ME, Buck GM, Lyon NR, Norris MK, Roland JM, Gingell RL, Cleveland DC, Pieroni DR. Neurodevelopmental outcome of infants with hypoplastic left heart syndrome. J Pediatr. 1995; 126: 496–498.[CrossRef][Medline] [Order article via Infotrieve]
39. Kern JH, Hinton VJ, Nereo NE, Hayes CJ, Gersony WM. Early developmental outcome after the Norwood procedure for hypoplastic left heart syndrome. Pediatrics. 1998; 102: 1148–1152.
40. Goldberg CS, Schwartz EM, Brunberg JA, Mosca RS, Bove EL, Schork MA, Stetz SP, Cheatham JP, Kulik TJ. Neurodevelopmental outcome of patients after the Fontan operation: a comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J Pediatr. 2000; 137: 646–652.[CrossRef][Medline] [Order article via Infotrieve]
41. Creighton DE, Robertson CM, Sauve RS, Moddemann DM, Alton GY, Nettel-Aguirre A, Ross DB, Rebeyka IM. Neurocognitive, functional, and health outcomes at 5 years of age for children after complex cardiac surgery at 6 weeks of age or younger. Pediatrics. 2007; 120: e478–e486.
42. Mahle WT, Visconti KJ, Freier MC, Kanne SM, Hamilton WG, Sharkey AM, Chinnock RE, Jenkins KJ, Isquith PK, Burns TG, Jenkins PC. Relationship of surgical approach to neurodevelopmental outcomes in hypoplastic left heart syndrome. Pediatrics. 2006; 117: e90–e97.
43. Visconti KJ, Rimmer D, Gauvreau K, del Nido P, Mayer JE Jr, Hagino I, Pigula FA. Regional low-flow perfusion versus circulatory arrest in neonates: one-year neurodevelopmental outcome. Ann Thorac Surg. 2006; 82: 2207–2211.
44. Goldberg CS, Bove EL, Devaney EJ, Mollen E, Schwartz E, Tindall S, Nowak C, Charpie J, Brown MB, Kulik TJ, Ohye RG. A randomized clinical trial of regional cerebral perfusion versus deep hypothermic circulatory arrest: outcomes for infants with functional single ventricle. J Thorac Cardiovasc Surg. 2007; 133: 880–887.
45. Borg E. Perinatal asphyxia, hypoxia, ischemia and hearing loss: an overview. Scand Audiol. 1997; 26: 77–91.[Medline] [Order article via Infotrieve]
46. Couture E, Riley P, Rohlicek C, Julien S, Zavalkoff B. Hearing loss in children with congenital heart defects. Paediatr Child Health. 2003; 8 (Suppl B): 29B–30B.Abstract.
| Footnotes |
|---|
Related Article:
Circulation 2008 118: 1403-1404.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |